ArticleCureus2024
Mesenteric Paraganglioma: An Unusual Suspect To Consider.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mesenteric paragangliomas (PGLs) are extremely rare, with a limited number of reported cases. These tumors are typically non-functioning and commonly manifest as a palpable abdominal mass or abdominal pain; however, a significant proportion of patients remain asymptomatic. Despite their rarity, they should be considered in the differential diagnosis of mesenteric masses. Surgical treatment is the preferred approach, and even after successful complete resection, long-term follow-up is crucial due to the unpredictable potential for metastasis. In this report, we describe the case of a 48-year-old male patient who presented with a self-limited episode of severe abdominal pain, without hyperfunctioning symptoms. The physical examination was unremarkable. Imaging studies revealed the presence of a mesenteric mass. The clinical, laboratory, imaging, and biopsy findings were insufficient to differentiate between an epithelial neuroendocrine tumor and a paraganglioma. Following a review by a neuroendocrine multidisciplinary team, surgery was proposed. While the initial suspicion was an epithelial neuroendocrine tumor, the histopathological examination of the surgical specimen was consistent with a PGL. Currently, after two years of follow-up, the patient remains asymptomatic and is undergoing regular clinical monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.